Literature DB >> 35701356

Identification of Spontaneous Shoulder Hemarthrosis with Point-of-Care Ultrasound in the Emergency Department.

Kevin A Padrez1, William Shyy1, Kavita Gandhi1, Nancy Anaya1, R Starr Knight1.   

Abstract

CASE
PRESENTATION: A 32-year-old man with a history of hemophilia A presented to the emergency department with right shoulder pain, swelling, and decreased range of motion. DISCUSSION: Emergency physicians can use ultrasound to quickly and accurately identify hemarthrosis at the bedside.

Entities:  

Year:  2022        PMID: 35701356      PMCID: PMC9197738          DOI: 10.5811/cpcem.2021.7.53408

Source DB:  PubMed          Journal:  Clin Pract Cases Emerg Med        ISSN: 2474-252X


CASE PRESENTATION

A 32-year-old man with a history of hemophilia A presented to the emergency department (ED) with right shoulder pain, swelling, and decreased range of motion. The patient had previously been treated with factor VIII replacement every three days for maintenance therapy but currently lacked access to established outpatient care after relocating from a nearby city. He was experiencing homelessness and sleeping outside. He denied preceding trauma, numbness, or weakness. His vital signs included: temperature 36.6ºC, heart rate 93 beats per minute, respiration rate 16 breaths per minute, blood pressure 173/127 millimeters mercury, and blood oxygen saturation of 100% on room air. His physical examination was remarkable for right shoulder swelling and tenderness along the right deltoid with decreased range of motion secondary to pain (Image 1). His distal motor and sensory function were intact.
Image 1

Photo of patient demonstrating asymmetric swelling of the right shoulder.

The treating emergency physician performed a point-of-care ultrasound to evaluate for a right shoulder hemarthrosis. This exam was performed using a curvilinear 5–2 megahertz probe (Sonosite, Bothell, WA). While standing behind the patient, the probe was placed parallel to the ground just below the scapular spine. The probe marker was oriented to the patient’s left, which allows the anatomy on the screen to match the patient’s anatomy. The probe was then moved laterally until the glenoid, humeral head, and infraspinatus tendon were visualized. Both the affected and unaffected shoulders were evaluated using a similar technique. In this patient, a collection with heterogeneous echogenicity was visualized above the humeral head and below the infraspinatus tendon, asymmetric to the unaffected side. These findings were consistent with a spontaneous hemarthrosis (Image 2). He was admitted to the hospital. Hematology was consulted and the patient was restarted on factor VIII treatment with improvement in his shoulder symptoms. He established care with the local hematology clinic to initiate regular factor VIII maintenance therapy.
Image 2

Ultrasound images of the affected right shoulder (2A) and unaffected left shoulder (2B) showing scapular spine (A), glenoid (B), humeral head (C) and infraspinatus tendon (D). A mixed-echotexture collection consistent with an intraarticular hemarthrosis (star) is visualized in the right shoulder.

DISCUSSION

Spontaneous hemarthrosis is a common cause of morbidity and pain for patients with congenital hemophilia.1 While magnetic resonance imaging (MRI) is considered the conventional imaging modality for evaluating hemophilic arthropathy, ultrasound offers many benefits including less time, lower cost, and better accessibility than MRI.2 The detection of a joint effusion remains a core use of point-of-care ultrasound in the ED3 and has also been shown to accurately diagnose hemarthrosis in the outpatient setting.4,5 Emergency physicians can use point-of-care ultrasound to quickly and accurately identify hemarthrosis and expedite care for hemophilia patients. The described technique to identify spontaneous hemarthrosis in the shoulder uses a curvilinear probe. The larger footprint of the probe allows for better visualization of the complete shoulder anatomy compared to a linear probe. However, a similar technique may be applied using the linear probe, especially in pediatric patients. Gentle internal and external rotation of the arm can help confirm the identification of the humeral head (video). Some small effusions may only be visible with external rotation of the affected arm. What do we already know about this clinical entity? Point-of-care ultrasound is commonly used to identify joint effusions. What is the major impact of the image(s)? Spontaneous shoulder hemarthrosis may be quickly and accurately identified using point-of-care ultrasound. How might this improve emergency medicine practice? Point-of-care ultrasound should be considered for the identification of spontaneous hemarthrosis in hemophilia patients presenting with joint pain. Gentle internal and external rotation of the shoulder can help identify humeral head. Annotation identifies the glenoid (Gl), humeral head (HH), and hemarthrosis (star).
  5 in total

1.  Ultrasonography in the monitoring of management of haemarthrosis.

Authors:  J A Aznar; L Abad-Franch; S Perez-Alenda; S Haya; A R Cid; F Querol
Journal:  Haemophilia       Date:  2011-04-19       Impact factor: 4.287

Review 2.  State-of-the-art imaging techniques for the evaluation of haemophilic arthropathy: present and future.

Authors:  A S Doria
Journal:  Haemophilia       Date:  2010-07       Impact factor: 4.287

3.  Emergency Ultrasound Imaging Criteria Compendium.

Authors: 
Journal:  Ann Emerg Med       Date:  2016-07       Impact factor: 5.721

4.  Point-of-care musculoskeletal ultrasound is critical for the diagnosis of hemarthroses, inflammation and soft tissue abnormalities in adult patients with painful haemophilic arthropathy.

Authors:  W Kidder; S Nguyen; J Larios; J Bergstrom; A Ceponis; A von Drygalski
Journal:  Haemophilia       Date:  2015-01-27       Impact factor: 4.287

Review 5.  Advances and challenges in hemophilic arthropathy.

Authors:  Tine Wyseure; Laurent O Mosnier; Annette von Drygalski
Journal:  Semin Hematol       Date:  2015-10-26       Impact factor: 3.851

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.